Hypertension in Tunisian adults attending primary care physicians (ETHNA-Tunisia).

Autor:	Boujnah R; CHU Mongi Slim La Soukra, Tunis, Tunisia, Tunisia., Nazek L; Novartis Pharma Maroc SA, Casablanca, Morocco., Maalej M; Novartis Pharma Maroc SA, Tunisia., Achhab YE; Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed Ben Abdellah, Morocco; Regional Centre for Careers Education and Training of Fez-Meknes, Morocco. Electronic address: youness_elachhab@yahoo.fr., Nejjari C; Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez, University Sidi Mohamed Ben Abdellah, Morocco; Mohammed VI University for Health Sciences, Casablanca, Morocco.
Jazyk:	angličtina
Zdroj:	Indian heart journal [Indian Heart J] 2018 Jul - Aug; Vol. 70 (4), pp. 544-547. Date of Electronic Publication: 2017 Nov 06.
DOI:	10.1016/j.ihj.2017.11.005
Abstrakt:	The aim of the Epidemiological Trial of Hypertension in North Africa (ETHNA-Tunisia) was to evaluate the prevalence and clinical profile of hypertension in a large sample of individuals in Tunisia. This was multicenter, epidemiological, cross-sectional study conducted in patients consulting primary care physicians in Tunisia. Mean age of 5802 individuals was 49.6±16.3years. The total prevalence of hypertension was 47.4% (adjusted for age: 26.9%). Control of hypertension was only 37.1%. Hypertension may also be underdiagnosed and ineffectively treated. Greater awareness and improved management of hypertension and cardiovascular risks are needed in Tunisia. (Copyright © 2017. Published by Elsevier B.V.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu